128 related articles for article (PubMed ID: 36503148)
21. Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring.
Luthra R; Patel KP; Reddy NG; Haghshenas V; Routbort MJ; Harmon MA; Barkoh BA; Kanagal-Shamanna R; Ravandi F; Cortes JE; Kantarjian HM; Medeiros LJ; Singh RR
Haematologica; 2014 Mar; 99(3):465-73. PubMed ID: 24142997
[TBL] [Abstract][Full Text] [Related]
22. Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care.
Sheffield BS; Beharry A; Diep J; Perdrizet K; Iafolla MAJ; Raskin W; Dudani S; Brett MA; Starova B; Olsen B; Cheema PK
Curr Oncol; 2022 Feb; 29(3):1326-1334. PubMed ID: 35323313
[No Abstract] [Full Text] [Related]
23. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.
Hovelson DH; McDaniel AS; Cani AK; Johnson B; Rhodes K; Williams PD; Bandla S; Bien G; Choppa P; Hyland F; Gottimukkala R; Liu G; Manivannan M; Schageman J; Ballesteros-Villagrana E; Grasso CS; Quist MJ; Yadati V; Amin A; Siddiqui J; Betz BL; Knudsen KE; Cooney KA; Feng FY; Roh MH; Nelson PS; Liu CJ; Beer DG; Wyngaard P; Chinnaiyan AM; Sadis S; Rhodes DR; Tomlins SA
Neoplasia; 2015 Apr; 17(4):385-99. PubMed ID: 25925381
[TBL] [Abstract][Full Text] [Related]
24. Validation and optimization of the Ion Torrent S5 XL sequencer and Oncomine workflow for BRCA1 and BRCA2 genetic testing.
Shin S; Kim Y; Chul Oh S; Yu N; Lee ST; Rak Choi J; Lee KA
Oncotarget; 2017 May; 8(21):34858-34866. PubMed ID: 28422718
[TBL] [Abstract][Full Text] [Related]
25. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing.
Van den Hoecke S; Verhelst J; Vuylsteke M; Saelens X
BMC Genomics; 2015 Feb; 16(1):79. PubMed ID: 25758772
[TBL] [Abstract][Full Text] [Related]
27. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
[TBL] [Abstract][Full Text] [Related]
28. Strategies for identification of somatic variants using the Ion Torrent deep targeted sequencing platform.
Deshpande A; Lang W; McDowell T; Sivakumar S; Zhang J; Wang J; San Lucas FA; Fowler J; Kadara H; Scheet P
BMC Bioinformatics; 2018 Jan; 19(1):5. PubMed ID: 29301485
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive Validation of Diagnostic Next-Generation Sequencing Panels for Acute Myeloid Leukemia Patients.
Wagner U; Wong C; Camenisch U; Zimmermann K; Rechsteiner M; Valtcheva N; Theocharides A; Widmer CC; Manz MG; Moch H; Wild PJ; Balabanov S
J Mol Diagn; 2022 Aug; 24(8):935-954. PubMed ID: 35718092
[TBL] [Abstract][Full Text] [Related]
30. Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations.
Tsongalis GJ; Peterson JD; de Abreu FB; Tunkey CD; Gallagher TL; Strausbaugh LD; Wells WA; Amos CI
Clin Chem Lab Med; 2014 May; 52(5):707-14. PubMed ID: 24334431
[TBL] [Abstract][Full Text] [Related]
31. Improved Variant Detection in Clinical Myeloid NGS Testing by Supplementing a Commercial Myeloid NGS Assay with Custom or Extended Data Filtering and Accessory Fragment Analysis.
Schejbel L; Novotny GW; Breinholt MF; El Fassi D; Schöllkopf C; Hogdall E; Nørgaard P
Mol Diagn Ther; 2021 Mar; 25(2):251-266. PubMed ID: 33687704
[TBL] [Abstract][Full Text] [Related]
32. Clinical Utility and Reimbursement of Next-Generation Sequencing-Based Testing for Myeloid Malignancies.
Soderquist CR; Freeman C; Lin WH; Leeman-Neill RJ; Gu Y; Carter MC; Stutzel KC; Sigcha E; Alobeid B; Fernandes H; Bhagat G; Mansukhani MM; Hsiao SJ
J Mol Diagn; 2024 Jan; 26(1):5-16. PubMed ID: 37981089
[TBL] [Abstract][Full Text] [Related]
33. Detection of variations and identifying genomic breakpoints for large deletions in the LDLR by Ion Torrent semiconductor sequencing.
Faiz F; Allcock RJ; Hooper AJ; van Bockxmeer FM
Atherosclerosis; 2013 Oct; 230(2):249-55. PubMed ID: 24075752
[TBL] [Abstract][Full Text] [Related]
34. Analysis of genetic variants in myeloproliferative neoplasms using a 22-gene next-generation sequencing panel.
Tan J; Chow YP; Zainul Abidin N; Chang KM; Selvaratnam V; Tumian NR; Poh YM; Veerakumarasivam A; Laffan MA; Wong CL
BMC Med Genomics; 2022 Jan; 15(1):10. PubMed ID: 35033063
[TBL] [Abstract][Full Text] [Related]
35. Variant call concordance between two laboratory-developed, solid tumor targeted genomic profiling assays using distinct workflows and sequencing instruments.
Hampel KJ; de Abreu FB; Sidiropoulos N; Peterson JD; Tsongalis GJ
Exp Mol Pathol; 2017 Apr; 102(2):215-218. PubMed ID: 28192086
[TBL] [Abstract][Full Text] [Related]
36. Targeted next-generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics.
Maes B; Willemse J; Broekmans A; Smets R; Cruys B; Put N; Madoe V; Janssen M; Soepenberg O; Bries G; Vrelust I; Achten R; Van Pelt K; Buvé K; Theunissen K; Peeters V; Froyen G
Int J Lab Hematol; 2017 Dec; 39(6):604-612. PubMed ID: 28722833
[TBL] [Abstract][Full Text] [Related]
37. Comparison of somatic variant detection algorithms using Ion Torrent targeted deep sequencing data.
Wang Q; Kotoula V; Hsu PC; Papadopoulou K; Ho JWK; Fountzilas G; Giannoulatou E
BMC Med Genomics; 2019 Dec; 12(Suppl 9):181. PubMed ID: 31874647
[TBL] [Abstract][Full Text] [Related]
38. Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.
Magaz M; Alvarez-Larrán A; Colomer D; López-Guerra M; García-Criado MÁ; Mezzano G; Belmonte E; Olivas P; Soy G; Cervantes F; Darnell A; Ferrusquía-Acosta J; Baiges A; Turon F; Hernández-Gea V; García-Pagán JC
J Hepatol; 2021 Jan; 74(1):89-95. PubMed ID: 32679300
[TBL] [Abstract][Full Text] [Related]
39. Analytical and Potential Clinical Performance of Oncomine Myeloid Research Assay for Myeloid Neoplasms.
Park J; Kim HS; Lee JM; Jung J; Kang D; Choi H; Lee GD; Son J; Park S; Cho BS; Kim HJ; Kim S; Lee JW; Chung NG; Cho B; Zhang H; Khazanov NA; Choi J; Jung JW; Kim Y; Kim M
Mol Diagn Ther; 2020 Oct; 24(5):579-592. PubMed ID: 32676933
[TBL] [Abstract][Full Text] [Related]
40. The Interpretation of Sequence Variants in Myeloid Neoplasms.
Hanbazazh M; Harada S; Reddy V; Mackinnon AC; Harbi D; Morlote D
Am J Clin Pathol; 2021 Oct; 156(5):728-748. PubMed ID: 34155503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]